ArticleBlood cancer discovery2026

Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.